Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 5,100 shares, an increase of 363.6% from the January 15th total of 1,100 shares. Based on an average daily volume of 13,000 shares, the short-interest ratio is currently 0.4 days.

Algernon Pharmaceuticals Stock Performance

Algernon Pharmaceuticals stock opened at $0.08 on Friday. Algernon Pharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.12. The firm’s 50 day moving average price is $0.05 and its two-hundred day moving average price is $0.06.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.